Of note, we included in the multivariate analysis patients whose tumors did not fall into TN or ER+/HER2- category as “other” category because one of the goals of the study was to determine if TMEM doorway density is an independent prognostic indicator of distant recurrence regardless of cancer subtype. This evidence concerns the gene ERBB2 and cancer.